Neutral Impact of SARS-CoV-2 Coinfection on the Recombination-Driven Evolution of Endemic HCoV-OC43
Viruses · 2025
DOI: 10.3390/v17091263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Xueling Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Hangzhou 310002, China. Hauptthemen laut MEDLINE: Coinfection, SARS-CoV-2, COVID-19, Recombination, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou Medical and Health Science and Technology Project (Grant numbers: A20200487), Zhejiang Provincial Key Laboratory Construction Project (2024ZY01026), a…, Hangzhou Medical and Health Science and Technology Project, Zhejiang Provincial Key Laboratory Construction Project.
Abstract (Originalsprache)
Knowledge gaps exist on whether SARS-CoV-2 co-infection alters recombination frequency or induces phylogenetic incongruities in endemic β-coronaviruses (HCoV-OC43, HCoV-HKU1), limiting our understanding of cross-species evolution. Among 7213 COVID-19 and 1590 non-COVID-19 acute respiratory cases (2021–2022) screened via multiplex PCR, β-coronavirus co-infections (SARS-CoV-2 + HCoV-OC43/HKU1) and single HCoV-OC43/HKU1 infections were identified. Whole-genome sequencing (Illumina NovaSeq) was performed. Phylogenies were reconstructed using Bayesian inference (MrBayes). Recombination was assessed via Bootscan analysis (SimPlot). Co-infection prevalence was low (0.51%, mainly HCoV-HKU1: 0.28%, HCoV-OC43: 0.11%). HCoV-OC43 diverged into lineage 1 (genotype K) and a novel recombinant lineage 2 (genotypes F/J/G/I segments), exhibiting accelerated evolution. HCoV-HKU1 remained genetically stable (genotype B). Co-infection status did not influence evolutionary outcomes. While SARS-CoV-2 co-infection may favor transmission of endemic HCoVs, their evolution appears driven by population-level selection, not co-infection. HCoV-OC43 underwent recombination-driven diversification, contrasting sharply with HCoV-HKU1’s stasis, highlighting distinct evolutionary strategies. Integrated genomic and clinical surveillance is critical for tracking coronavirus adaptation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Hangzhou 310002, China.
- Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, Hangzhou 310002, China.
ORCID-Profile: Yue Yu
Förderung
- Hangzhou Medical and Health Science and Technology Project (Grant numbers: A20200487), Zhejiang Provincial Key Laboratory Construction Project (2024ZY01026), a…
- Hangzhou Medical and Health Science and Technology Project
- Zhejiang Provincial Key Laboratory Construction Project
- Construction Fund of Key Medical Disciplines of Hangzhou
Zitieren
APA
Zheng, X., Zhou, Y., Yu, Y., Cheng, S., Cao, F., Sun, Z., Li, J., & Yu, X. (2025). Neutral Impact of SARS-CoV-2 Coinfection on the Recombination-Driven Evolution of Endemic HCoV-OC43. Viruses. https://doi.org/10.3390/v17091263
Vancouver
Zheng X, Zhou Y, Yu Y, Cheng S, Cao F, Sun Z, et al. Neutral Impact of SARS-CoV-2 Coinfection on the Recombination-Driven Evolution of Endemic HCoV-OC43. Viruses. 2025. doi:10.3390/v17091263
BibTeX
@article{Zheng2025,
author = {Zheng, Xueling and Zhou, Yinyan and Yu, Yue and Cheng, Shi and Cao, Feifei and Sun, Zhou and Li, Jun and Yu, Xinfen},
title = {Neutral Impact of SARS-CoV-2 Coinfection on the Recombination-Driven Evolution of Endemic HCoV-OC43},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17091263}
}
EUVIMED